Affiliate

Allen Chen

Allen Chen

ADROP President

University of California, Irvine - Chao Family Comprehensive Cancer Center

Education

  • MD, Medicine, Yale University, New Haven, Connecticut, 2001.
  • BA, Biology and American History, Cornell University, Ithaca, N.Y., 1996.

Postgraduate Education

  • Residency, Radiation Oncology, University of California, San Francisco, 2003-2006.
  • Chief Resident, Radiation Oncology, University of California, San Francisco, 2005-2006.
  • Residency, Radiation Oncology, MD Anderson Cancer Center, Houston, 2002-2003.
  • Internship, Internal Medicine, Kaiser Permanente, Santa Clara, California, 2001-2002.

Academic Appointments

  • Professor and Chair, Radiation Oncology, University of California, Irvine, California  2018-present.
  • Residency Program Director, Radiation Oncology, University of California, Irvine, California 2018-present.
  • Professor and Chair, Radiation Oncology, University of Kansas, Kansas City, 2016-2018.
  • Residency Program Director, Radiation Oncology, University of Kansas, Kansas City, 2016-2018.
  • Professor, Radiation Oncology, University of California, Los Angeles, 2015-2016.
  • Vice Chair, Education, Radiation Oncology, University of California, Los Angeles, 2013-2016.
  • Residency Program Director, Radiation Oncology, University of California, Los Angeles, 2013-2016.
  • Associate Professor, Radiation Oncology, University of California, Los Angeles, 2013-2015.
  • Residency Program Director, Radiation Oncology, University of California Davis, California, 2008-2012.
  • Associate Professor, Radiation Oncology and Otolaryngology - Head and Neck Surgery, University of California, Davis, California, 2012-2013.
  • Assistant Professor, Radiation Oncology, University of California, Davis, California., 2007-2012.

Hospital/Institution Appointments

  • University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, California, 2018-present.

Biographical Statement

Dr. Chen is Chair and Professor in the Department of Radiation Oncology at the University of California, Irvine School of Medicine. His research focuses on the use of innovative approaches utilizing advanced technologies and radiosensitizers to optimize cure rates for patients with head and neck cancer. Dr. Chen serves on both the education and the scientific program committees for the American Society for Radiation Oncology (ASTRO), is a principle investigator for several key ongoing multi-institutional studies, including those involving the NRG Oncology Consortium and the Southwestern Oncology Group (SWOG), and is a member of several National Cancer Institute (NCI) task forces focused on clinical trial development. In addition to being a residency program director for over 10 years, he serves as a faculty advisor for the Association of Residents in Radiation Oncology (ARRO).

We have recently updated our privacy policy and terms of use.
By using this site, you agree to ASTRO’s Privacy Policy and Terms of Use.
We use cookies to provide, secure and improve our services to you. To learn more, click here.